Ionis Pharmaceuticals

Ionis Pharmaceuticals Delivering innovative medicines to patients where no others have proven effective or existed.

09/02/2026

The beach is nature’s playground, and we had a blast transforming it into an inclusive venue for people living with neurological conditions, and their families and caregivers, at our 11th annual Surf Away+.

With the help of Ionis volunteers and partners, we facilitated adaptive and accessible activities to engage and delight attendees, including music and movement, sensory activations from tidepool tanks to STEM learning, workshops that included art, mindfulness and improv, adaptive surfing, pickleball, volleyball and more.

Surf Away+ is a day for the whole family, and this year we celebrated siblings and the important role they play alongside parents and caregivers.

We want to extend a huge thank-you to all participants, family members, partners and volunteers who made this a day of joy and support for such a deserving community.

Partners: Adapt, Challenged Athletes Foundation, Waves4all

Resources: Angelman Syndrome Foundation, Rare Mamas, Raregivers, Pawsitive Teams, Inc., Resounding Joy Inc.

08/18/2026

Ionis Every Step™ provides personal support and tools to help people living with serious diseases as they get started on an Ionis medication.

Our dedicated Patient Education Managers work to understand each person’s unique journey so they can personalize care, including disease education, insurance navigation and community resources.

Learn more at everystep.ionis.com.

08/10/2026

We’re pleased to share that Ionis has made San Diego Business Journal’s 2026 Best Places to Work list for the third consecutive year, climbing into the #3 spot.

This recognition is a testament to all Ions who foster our culture of collaboration and innovation through their commitment to improving the lives of patients living with serious diseases.

Learn more about this achievement: https://ionis.com/newsroom/people-impact/ionis-recognized-top-3-best-place-work-san-diego-business-journal

08/06/2026

Yajaira, a mom of two young girls, finds joy in spending time with her family. On the outside, you’d never expect that anything was wrong. However, on the inside, she’s living with very high , known as severe hypertriglyceridemia ( ).

sHTG, defined as triglycerides 500 mg/dL or above, can affect how a person feels every day, with some reporting changes that affected their mood, energy and overall well-being.

By raising awareness of sHTG, we are committed to helping people like Yajaira feel seen.

Hear more from Yajaira about her experience: https://ionis.com/newsroom/patient-voices/severe-hypertriglyceridemia-invisible-illness-story

It was a pleasure to join more than 2,000 members of the (AS) community at the Angelman Syndrome Foundation’s Family C...
08/05/2026

It was a pleasure to join more than 2,000 members of the (AS) community at the Angelman Syndrome Foundation’s Family Conference and Research Symposium in Aurora, Colorado last week.

The power of this event lies in creating opportunities for community members to connect, learn from one another and build new skills and for researchers and clinicians to share the latest advancements in care.

A key theme this year was transitions. AS is not just a childhood disease and can affect people of all ages. Attendees were encouraged to consider how families can prepare to transition someone with AS into a new school or adult care setting. Learn more here: https://angelman.org/asgrowsup/

At Ionis, we empower our communities by sharing our passion for STEM education with the next generation. Recently, throu...
07/31/2026

At Ionis, we empower our communities by sharing our passion for STEM education with the next generation. Recently, through our Education Workforce Partnerships, we welcomed a group of high-achieving STEM students from California State University, San Marcos' Summer Scholars program to our Carlsbad campus for a tour of our professional laboratory environment, an interviewing workshop and a career panel.

See some of the advice Ionis panelists shared about the endless possibilities of a career in life sciences and learn more at Ionis.com/careers.

07/23/2026

For more than three decades, our purpose, people and passion have come together to help turn scientific progress into possibilities for people living with serious diseases. Visit Ionis.com to learn more.

07/17/2026

In our latest Ask an Ion, Evan shares a glimpse into his role as a senior research associate in Manufacturing & Operations at Ionis and answers one question you probably never thought to ask: what piece of manufacturing equipment would you be and why?

Watch the video to see the unique perspective and sense of humor Evan brings to the work he does at Ionis.

06/24/2026

Today, the U.S. FDA approved our medicine for severe hypertriglyceridemia ( ) to reduce triglycerides and the risk of acute pancreatitis – marking a historic advance in lipid management for patients.

06/24/2026

Cecilia was diagnosed with severe hypertriglyceridemia ( ) after she collapsed on the street with acute pancreatitis, a complication of very high that are 500 mg/dL or higher.

Now, she is sharing her story to bring hope to others who may be living with very high triglycerides.

We’re conducting innovative research for people like Cecilia, who are still fighting for better.

Address

2855 Gazelle Court
Carlsbad, CA
92010

Telephone

(760) 931-9200

Website

Alerts

Be the first to know and let us send you an email when Ionis Pharmaceuticals posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Ionis Pharmaceuticals:

Shortcuts

Share

Category